These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23798671)

  • 1. Proteome profiles of vaginal fluids from women affected by bacterial vaginosis and healthy controls: outcomes of rifaximin treatment.
    Cruciani F; Wasinger V; Turroni S; Calanni F; Donders G; Brigidi P; Vitali B
    J Antimicrob Chemother; 2013 Nov; 68(11):2648-59. PubMed ID: 23798671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota.
    Cruciani F; Brigidi P; Calanni F; Lauro V; Tacchi R; Donders G; Peters K; Guaschino S; Vitali B
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4062-70. PubMed ID: 22585228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of abnormal vaginal flora in Ugandan women by self-testing and short use of intravaginal antimicrobials.
    Donders G; Bellen G; Donders F; Pinget J; Vandevelde I; Michiels T; Byamughisa J
    Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):731-738. PubMed ID: 27933401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis.
    Laghi L; Picone G; Cruciani F; Brigidi P; Calanni F; Donders G; Capozzi F; Vitali B
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3411-20. PubMed ID: 24709255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, double-blind, randomized, placebo-controlled study of rifaximin for the treatment of bacterial vaginosis.
    Donders GG; Guaschino S; Peters K; Tacchi R; Lauro V;
    Int J Gynaecol Obstet; 2013 Feb; 120(2):131-6. PubMed ID: 23273888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a microarray-based tool to characterize vaginal bacterial fluctuations and application to a novel antibiotic treatment for bacterial vaginosis.
    Cruciani F; Biagi E; Severgnini M; Consolandi C; Calanni F; Donders G; Brigidi P; Vitali B
    Antimicrob Agents Chemother; 2015 May; 59(5):2825-34. PubMed ID: 25733514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
    Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
    BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of bacterial vaginosis with high dosage metronidazole and lactic acid].
    Andreeva P; Slavchev B; Kovachev S; Nacheva A; Vacheva R
    Akush Ginekol (Sofiia); 2002; 41(5):36-9. PubMed ID: 12440337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy.
    Donders GG; Van Calsteren K; Bellen G; Reybrouck R; Van den Bosch T; Riphagen I; Van Lierde S
    BJOG; 2009 Sep; 116(10):1315-24. PubMed ID: 19538417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacterial vaginosis: efficacy of a local treatment with a gel containing a fraction derived from propinibacterium acnes].
    Melis GB; Marotto MF; Orrù MM; Pilloni M; Zedda P; D'Alterio M; Paoletti AM
    Minerva Ginecol; 2016 Feb; 68(1):1-8. PubMed ID: 26990097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic signatures of bacterial vaginosis.
    Srinivasan S; Morgan MT; Fiedler TL; Djukovic D; Hoffman NG; Raftery D; Marrazzo JM; Fredricks DN
    mBio; 2015 Apr; 6(2):. PubMed ID: 25873373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples - A pilot study.
    Plummer EL; Vodstrcil LA; Danielewski JA; Murray GL; Fairley CK; Garland SM; Hocking JS; Tabrizi SN; Bradshaw CS
    PLoS One; 2018; 13(1):e0190199. PubMed ID: 29293559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a TH1-shift of local vaginal inflammatory response during bacterial vaginosis.
    Anton G; Rid J; Mylonas I; Friese K; Weissenbacher ER
    Infection; 2008 Mar; 36(2):147-52. PubMed ID: 18330506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study on vaginal or oral treatment of bacterial vaginosis.
    Mikamo H; Kawazoe K; Izumi K; Watanabe K; Ueno K; Tamaya T
    Chemotherapy; 1997; 43(1):60-8. PubMed ID: 8996744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of vitamin C vaginal tablets in the treatment of bacterial vaginosis: a randomised, double blind, placebo controlled clinical trial.
    Petersen EE; Genet M; Caserini M; Palmieri R
    Arzneimittelforschung; 2011; 61(4):260-5. PubMed ID: 21650086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal retention of locally administered clindamycin.
    Eriksson K; Larsson PG; Nilsson M; Forsum U
    APMIS; 2011 Jun; 119(6):373-6. PubMed ID: 21569095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis.
    Marrazzo JM; Cook RL; Wiesenfeld HC; Murray PJ; Busse B; Krohn M; Hillier SL
    J Womens Health (Larchmt); 2006 Nov; 15(9):1053-60. PubMed ID: 17125424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy.
    Hanson JM; McGregor JA; Hillier SL; Eschenbach DA; Kreutner AK; Galask RP; Martens M
    J Reprod Med; 2000 Nov; 45(11):889-96. PubMed ID: 11127100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of intravaginal clindamycin and metronidazole therapy on vaginal mobiluncus morphotypes in patients with bacterial vaginosis.
    Nyirjesy P; McIntosh MJ; Steinmetz JI; Schumacher RJ; Joffrion JL
    Sex Transm Dis; 2007 Apr; 34(4):197-202. PubMed ID: 17179772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis.
    Sobel J; Peipert JF; McGregor JA; Livengood C; Martin M; Robbins J; Wajszczuk CP
    Infect Dis Obstet Gynecol; 2001; 9(1):9-15. PubMed ID: 11368263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.